Trial Details

COMPLETED
Basic Information
Clinical ID c3829
Identifier NCT01470599
Trial Title A Open-Label Study Of CP-690,550 As Long-Term Therapy (48 Weeks) In Subjects With Crohn's Disease
Trial URL Visit Original Page
Study Information
Study Results

YES
Conditions Crohn's Disease
Interventions DRUG: CP-690,550|DRUG: CP-690,550
Participant Information
Sponsor Pfizer
City Oceanside
Country/Region United States
Enrollment Criteria
Sex Requirement ALL
Age Requirement ADULT, OLDER_ADULT
Study Design
Study Type INTERVENTIONAL
Phase PHASE2
Time Information
Start Date 2012-04
Primary Completion Date 2016-07
Completion Date 2016-07